Genmab — Marts 2017
-
Genmab-konkurrent skal stoppe kliniske forsøg
Et amerikansk biotekselskab har fået at vide, at de midlertidigt skal stoppe udviklingen af deres primære lægemiddelkandidat, fordi der har været problemer i forhold til information om bivirkningerne af midlet.
(medwatch.dk)
-
Der er stor omsætning på Bavarian idag

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
